Work

Natalizumab Therapy for Moderate to Severe Crohn Disease in Adolescents

Year: 2007

Type: article

Study design: Clinical Trial

Source: Journal of Pediatric Gastroenterology and Nutrition

DOI: 10.1097/01.mpg.0000252191.05170.e7

Authors: Jeffrey S Hyams, David C Wilson, Adrian Thomas, Robert Heuschkel, Sally Mitton, Brent Mitchell, Regina Daniels, Michele A Libonati, Susan Zanker, Subra Kugathasan, International Natalizumab CD305 Trial Group

Institutions: Connecticut Children's Medical Center, Royal Hospital for Sick Children, University of Edinburgh, The Royal Free Hospital, St George's Hospital, St George's, University of London, Launceston General Hospital, Elan Pharmaceuticals, Inc. (Ireland), Medical College of Wisconsin

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1975066524

FWCI: 5.018

Cites: 22

Cited by: 62

Related to: 10